| Literature DB >> 16249956 |
Joseph M Harrison1, Randolph D Glickman, Charles S Ballentine, Yolanda Trigo, Melanie A Pena, Pearl Kurian, Laura K Najvar, Neeru Kumar, Ankit H Patel, William E Sponsel, John R Graybill, William C Lloyd, Margaret M Miller, Gianmarco Paris, Fernando Trujillo, Aaron Miller, Robert Melendez.
Abstract
This study was conducted to evaluate the effectiveness of a new antifungal drug, micafungin, and standard antifungal drugs against endophthalmitis induced in a rabbit by intravitreal injection of Aspergillus fumigatus, an important fungal pathogen. Effectiveness was evaluated by the preservation of b-wave amplitude at 72 h after injection of the fungus relative to the b-wave amplitude at baseline before any intravitreal injections. A 0.06 ml inoculum of 10(6) conidia of A. fumigatus was injected into the vitreous of the right eye of all rabbits; and, 12 h later, a 0.06 ml solution containing one of 3 antifungal drugs or saline was injected into the vitreous of both eyes. All three antifungal drugs produced significant b-wave preservation at 72 h in infected eyes compared to that in infected eyes receiving saline injections. There was no statistically significant difference between the effects of micafungin and amphotericin B in the right eyes with fungal endophthalmitis, and both produced significantly more preservation of b-wave amplitude than voriconazole. Amphotericin B, but neither micafungin nor voriconazole produced significant reduction of the b-wave amplitude in the left eyes.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16249956 DOI: 10.1007/s10633-005-7342-0
Source DB: PubMed Journal: Doc Ophthalmol ISSN: 0012-4486 Impact factor: 2.379